| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.13B | 21.76B | 21.25B | 21.14B | 20.60B | 18.74B |
| Gross Profit | 6.15B | 6.71B | 5.96B | 6.47B | 6.06B | 5.65B |
| EBITDA | 1.66B | 2.20B | 1.70B | 2.45B | 2.31B | 2.02B |
| Net Income | 1.08B | 1.59B | 1.12B | 1.74B | 1.40B | 1.07B |
Balance Sheet | ||||||
| Total Assets | 26.45B | 28.75B | 26.56B | 24.63B | 20.91B | 19.28B |
| Cash, Cash Equivalents and Short-Term Investments | 4.54B | 4.80B | 4.00B | 3.28B | 2.36B | 2.43B |
| Total Debt | 3.69B | 3.95B | 3.54B | 2.61B | 1.08B | 698.59M |
| Total Liabilities | 7.98B | 8.42B | 7.80B | 7.06B | 5.04B | 4.77B |
| Stockholders Equity | 18.17B | 19.99B | 18.44B | 17.28B | 15.62B | 14.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 562.35M | 476.07M | 1.06B | -305.14M | 135.56M |
| Operating Cash Flow | 0.00 | 1.39B | 1.47B | 1.43B | 308.73M | 1.32B |
| Investing Cash Flow | 0.00 | -758.43M | -1.44B | -1.62B | -520.00M | -833.87M |
| Financing Cash Flow | 0.00 | -9.96M | 642.50M | 1.07B | 117.00M | -523.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥23.13B | 8.13 | ― | 2.87% | 3.04% | 38.35% | |
75 Outperform | ¥10.51B | 6.63 | ― | 2.89% | 2.40% | 41.67% | |
73 Outperform | ¥8.81B | 9.18 | ― | 2.92% | 4.05% | 187.83% | |
65 Neutral | ¥17.53B | 5.19 | ― | 4.33% | 2.56% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥10.47B | 39.24 | ― | 3.48% | 3.10% | -60.12% | |
46 Neutral | ¥4.34B | -1.75 | ― | 1.06% | 8.16% | -1033.34% |